Attached files

file filename
EX-21.1 - EX-21.1 - Harmony Biosciences Holdings, Inc.d755703dex211.htm
EX-10.15 - EX-10.15 - Harmony Biosciences Holdings, Inc.d755703dex1015.htm
EX-10.14 - EX-10.14 - Harmony Biosciences Holdings, Inc.d755703dex1014.htm
EX-10.13 - EX-10.13 - Harmony Biosciences Holdings, Inc.d755703dex1013.htm
EX-10.12 - EX-10.12 - Harmony Biosciences Holdings, Inc.d755703dex1012.htm
EX-10.11 - EX-10.11 - Harmony Biosciences Holdings, Inc.d755703dex1011.htm
EX-10.10 - EX-10.10 - Harmony Biosciences Holdings, Inc.d755703dex1010.htm
EX-10.2 - EX-10.2 - Harmony Biosciences Holdings, Inc.d755703dex102.htm
EX-10.1 - EX-10.1 - Harmony Biosciences Holdings, Inc.d755703dex101.htm
EX-3.3 - EX-3.3 - Harmony Biosciences Holdings, Inc.d755703dex33.htm
EX-3.2 - EX-3.2 - Harmony Biosciences Holdings, Inc.d755703dex32.htm
EX-3.1 - EX-3.1 - Harmony Biosciences Holdings, Inc.d755703dex31.htm
S-1 - S-1 - Harmony Biosciences Holdings, Inc.d755703ds1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated April 10, 2020, relating to the financial statements of Harmony Biosciences Holdings, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Chicago, Illinois

July 27, 2020